Radcliffe Capital Management, L.P. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 77 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$4,613,271
+1.8%
456,7640.0%0.15%
+33.9%
Q3 2022$4,533,000
+12.8%
456,764
+12.5%
0.11%
+18.5%
Q2 2022$4,018,000
+0.4%
405,9000.0%0.09%
+1.1%
Q1 2022$4,002,000
+0.2%
405,9000.0%0.09%
-13.3%
Q4 2021$3,994,000
+1.0%
405,9000.0%0.10%
-8.7%
Q3 2021$3,953,000
+0.7%
405,9000.0%0.12%
-6.5%
Q2 2021$3,925,000405,9000.12%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOTECH ACQUISITION COMPANY shareholders